U.S. Food and Staples Retail Stock News

Klarna has already launched instant peer-to-peer payments across 13 European countries, letting users send money directly within the Klarna app as it pushes further into everyday digital banking. This move deepens Klarna’s role as a day-to-day money hub, extending its reach beyond buy now, pay later into broader consumer financial services. Next, we’ll examine how Klarna’s expansion into peer-to-peer payments could reshape its investment narrative as a broader digital bank. Uncover the next...

Earlier this month, TTM Technologies’ CEO Edwin Roks and CFO Dan Boehle outlined at the Needham Growth Conference that the company is targeting annual revenue growth of 15–20% over the next three years and aims to double earnings between 2025 and 2027, supported by demand in aerospace, defense, and AI-driven data center computing. This combination of explicit multi‑year growth goals and exposure to AI infrastructure and high-reliability defense electronics has sharpened how investors assess...

Kyivstar Group (KYIV) shares have pulled back sharply over the past month, even as the company reports annual revenue of $1.086b and net income of $127.0m. That mix of pressure and profitability is what investors are weighing now. See our latest analysis for Kyivstar Group. Looking beyond the recent pullback, the 30 day share price return of 19.74% and year to date share price return of 8.67% compare with a 1 year total shareholder return of 18.94%. This points to earlier strength now giving...

Raymond James cut its rating on Hess Midstream (HESM) to Market Perform as part of a broader midstream review, even as the partnership continued executing on its distribution framework and share repurchase plans. See our latest analysis for Hess Midstream. At a share price of $34.89, Hess Midstream has seen a 7-day share price return of 3.87% and a 90-day share price return of 6.76%. Its 3-year total shareholder return of 40.45% and 5-year total shareholder return of 137.98% point to stronger...

In January 2026, Guardant Health reported unaudited revenue of approximately US$280 million for Q4 and US$981 million for 2025, reflecting strong year-on-year growth across its oncology and Shield colorectal cancer screening tests. At the same time, TRICARE’s decision to cover Guardant’s FDA-approved Shield blood test for colorectal cancer screening with no copay for eligible active-duty service members and families significantly broadens access to this non-invasive screening option within...

Why Avnet Stock Is On Investors’ Radar Avnet (AVT) has attracted fresh attention after recent share price moves, with a 2.3% gain over the past week and about 4.8% over the past month offering a timely moment to reassess the stock. See our latest analysis for Avnet. The recent 1-day share price return of 2.26% and 30-day share price return of 4.75%, against a flatter 90-day share price picture, sit alongside a 1-year total shareholder return that is roughly unchanged and stronger 3-year and...

As the U.S. stock market experiences fluctuations with AI stocks cooling off and major indexes like the Dow Jones wavering, investors are closely watching for opportunities in a climate of mixed economic signals and steady Treasury yields. In this environment, identifying undervalued stocks becomes crucial as they can offer potential value by trading below their intrinsic worth, providing a strategic entry point for those looking to navigate current market conditions effectively.

As the U.S. stock market experiences fluctuations with AI stocks cooling off and major indexes wavering, investors are keenly observing companies that demonstrate resilience and growth potential. In this environment, growth companies with substantial insider ownership and strong revenue growth stand out as promising candidates for those seeking stability and potential upside in their investment portfolios.

As the AI stock rally cools, major U.S. indexes have been wavering, reflecting a broader market uncertainty. For investors willing to explore beyond well-known stocks, penny stocks—often representing smaller or newer companies—can offer intriguing opportunities. Despite being considered a somewhat outdated term, penny stocks remain relevant for those seeking affordable entry points with potential growth prospects and financial resilience.

In recent days, Asana reported third-quarter fiscal 2026 results that were ahead of expectations, while sector-wide worries about AI, commoditization, and geopolitical tensions weighed on the broader enterprise software group. The reaction highlights how investor sentiment toward Asana is currently being driven more by industry-wide concerns and competitive pressures than by changes in its own operating performance. We’ll now explore how sector-wide concerns about commoditization and...

Product launch at World of Concrete puts focus on SWK’s tools business Stanley Black & Decker (SWK) is attracting fresh attention after its DEWALT brand unveiled new POWERSHIFT concrete tools at the 2026 World of Concrete Trade Show, highlighting battery tech, safety features, and jobsite productivity. See our latest analysis for Stanley Black & Decker. The DEWALT POWERSHIFT launch comes at a time when momentum in Stanley Black & Decker’s shares has been picking up. The 30 day share price...

If you are wondering whether Alexandria Real Estate Equities is priced attractively right now, you are not alone, especially with so much attention on real estate stocks and their underlying assets. The share price recently closed at US$57.26, with returns of 7.5% over 7 days and 21.9% over 30 days. However, the 1 year, 3 year, and 5 year returns of negative 39.1%, negative 56.8%, and negative 59.0% show a very different picture. These moves have put Alexandria Real Estate Equities back on...

Why Radware’s AI Security Discovery Matters for Investors Radware (RDWR) recently reported the discovery of ZombieAgent, a zero-click indirect prompt injection vulnerability in OpenAI’s Deep Research agent, exposing risks such as invisible data theft and persistent agent hijacking for enterprise users. The company plans to publish full technical details and defense guidance through its Security Research Center. This keeps the focus on how its cybersecurity capabilities align with demand for...

Ascendis Pharma (NasdaqGS:ASND) is back in focus after releasing Week 52 topline data from its Phase 2 COACH trial, in which once weekly TransCon CNP and TransCon hGH combination therapy produced durable growth and proportionality benefits. See our latest analysis for Ascendis Pharma. Investors appear to be weighing the fresh COACH trial readout against Ascendis Pharma’s recent share price performance. The stock is at US$215.04 after a 3.0% 7 day share price gain and a 63.4% 1 year total...

If you are wondering whether DNOW's current share price gives you enough value for the risk you are taking, this article walks through what the numbers are actually saying. The stock last closed at US$14.34, with returns of 4.7% over 7 days, 4.1% over 30 days, 7.3% year to date, 5.7% over 1 year, 16.3% over 3 years and 76.2% over 5 years, which many investors use as a starting point when thinking about potential value or shifting risk perceptions. Recent attention on DNOW has been shaped by...

Value Holdings Management’s recent purchase of 98,289 shares in Euronet Worldwide (EEFT) follows a quarter in which revenue grew 4% and adjusted EPS rose 19%, with management guiding to 12% to 16% full year EPS growth. See our latest analysis for Euronet Worldwide. Even with the latest earnings update and fresh interest from Value Holdings Management, Euronet Worldwide’s share price has been under pressure, with a 90 day share price return showing a 14.47% decline and a 1 year total...

Canaan (CAN) is back in the spotlight after reporting unaudited operating results that include higher deployed hashrate, record bitcoin and ethereum holdings, and a renewed US$30 million share repurchase program. See our latest analysis for Canaan. Despite the recent operational updates and the new Canadian heat reuse pilot, momentum in the stock has been mixed, with a 3.29% 30 day share price return, a 48.74% 90 day share price decline, and a 56.84% 1 year total shareholder return...

If you are wondering whether Simon Property Group is still reasonably priced at around US$182, this article walks through what the current share price might be implying about its value. The stock is close to its recent level at US$182.31, with a 1% decline over the last 7 days, a flat 0.1% decline over 30 days, and returns of 10.9% over 1 year, 77.3% over 3 years and 151.6% over 5 years, which may have shifted how investors are thinking about risk and reward. Recently, headlines around Simon...

CarGurus (CARG) has been drawing attention after recent share price moves, with the stock now around US$34.74. For investors, the key question is how this lines up with the company’s fundamentals. See our latest analysis for CarGurus. Recent trading has been choppy, with a 7 day share price return of a 10.05% decline and a 30 day share price return of a 9.03% decline. However, the 3 year total shareholder return of 119.73% points to much stronger longer term momentum that has cooled...

Urban Edge Properties (UE) is drawing attention after a mixed return picture. The stock has been roughly flat over the past year, while showing gains over the past 3 years and 5 years. See our latest analysis for Urban Edge Properties. The recent 7 day and 30 day share price returns of 3.57% and 4.11% declines, alongside a 6.14% decline over 90 days, suggest momentum has cooled recently even though the 3 year and 5 year total shareholder returns of 38.52% and 60.52% still point to a stronger...

If you are wondering whether Tripadvisor's current share price reflects its real worth, you are not alone. Many investors are asking whether the stock still offers value after a tough run. The shares last closed at US$13.99, with returns of a 5.7% decline over 7 days, 6.4% decline over 30 days, 4.4% decline year to date, 10.7% decline over 1 year, 35.8% decline over 3 years and 58.4% decline over 5 years. This performance has naturally raised questions about both risk and potential...

If you are wondering whether Gap's current share price really reflects its underlying value, you are not alone. This article is built to help you frame that question clearly. The stock closed at US$27.28, with a 4.0% decline over the last 7 days, a 0.8% gain over 30 days, 8.3% gain year to date, 23.7% gain over 1 year, and a very large 3 year return that is around 1.4x, alongside a 46.3% gain over 5 years. These figures can change how investors think about both risk and opportunity. Recent...

Sana Biotechnology (SANA) used its appearance at the 44th Annual J.P. Morgan Healthcare Conference to share updated data on its UP421 cell therapy and pipeline programs SC451 and SG293, sharpening the story around its clinical progress. See our latest analysis for Sana Biotechnology. Those conference updates land after a mixed stretch for the stock, with a 7 day share price return of 3.32% compared with a 30 day share price return decline of 6.60%. Meanwhile, the 1 year total shareholder...

Why SPX Technologies is on investors’ radar today SPX Technologies (SPXC) has drawn fresh attention after recent trading left the stock around $213.61, with performance over the past month, past 3 months, and year giving investors more data to assess. See our latest analysis for SPX Technologies. The recent move to a share price of $213.61 comes after a 1-day share price return of 1.83% and a 7-day share price return of 2.97%, set against a 90-day share price return of 16.07% and a 1-year...